Globally, few children with drug-resistant (DR) tuberculosis (TB) are identiﬁed, diagnosed, and given an appropriate treatment. Although advances have been made in critical high burden countries such as Bangladesh to increase access to quality care and treatment for DR TB, this disease is still considered largely to be a problem for adults, and children who are infected remain too often in the shadows, unable to access care. A child
The USAID TB CARE II Project, a five-year project implemented by a wide consortium of health and development organizations including and led by University Research Co., LLC (URC), began in 2010 with the aim of complementing and building upon existing and planned projects in the Bureau for Global Health to provide global leadership and support to National TB Programs and other in-country partners. Since then, the project team has
Over the past 20 years, Bangladesh has made significant progress in detecting, diagnosing, and treating Tuberculosis (TB). Despite this progress, TB remains a significant threat to people living in the country. The USAID-funded TB CARE II Bangladesh project provides leadership and support to the National Tuberculosis Control Program (NTP) and local partners to increase access to high-quality treatment services in the effort to stop the spread of TB. As
An effective tuberculosis (TB) control program requires early diagnosis and immediate initiation into treatment to reduce transmission. In 2011, recognizing this fact, the USAID funded TB CARE II Project developed a framework for analyzing TB delay along with a set of tools to collect data on patient delays. TB CARE II then conducted field assessments using these tools in two high-burden TB countries— Bangladesh and Swaziland—in order to identify specific
In recent years, national health programs have expanded their focus to include not only improving access to care, but also improving the quality of care received by patients and communities. As part of quality assurance for many clinical diseases, including tuberculosis (TB), international and national evidence-based standards and guidelines have been developed. Having explicit standards and guidelines helps ensure high-quality care, better health outcomes, and cost-effective treatments. In addition, they
Improving management of Multi-Drug-resistant TB (MDR TB) is a special focus of the TB CARE II project. It is estimated that there are 3,800 MDR TB cases annually in Bangladesh. A large proportion of these cases remain undetected and untreated, potentially increasing the risk of infection in the community. It is not possible to combat the threat of MDR TB without a synchronized effort to expand national capacity both
Bangladesh is a low-income country with the population of 150.5 million. TB remains a major public health problem in Bangladesh: the country is among both high TB and high MDR-TB burden countries. More than 170,000 cases of TB including 106,790 smear positives were notified in 2012. Approximately, 70,000 people die from TB every year. The estimated MDR-TB burden is 1.4% among the new and 29% among the retreatment cases.
In the past 2 years the TB CARE II Project has made significant achievements in fighting against TB in Bangladesh. Key achievements include improved access to quality TB and MDR-TB Services, Laboratory Quality Assurance, Development of cPMDT Standard Operating Procedures, strengthening of social support services for MDR TB patients and strengthened support systems for the effective delivery of TB services at all levels.
TB CARE II is working throughout Bangladesh to raise awareness of TB among vulnerable groups, including children, urban and rural populations, and low-income populations. World TB Day 2014 is a great opportunity to disseminate TB messages that specifically target these groups. For example, to successfully reach children and their parents TB CARE II decided to go where children congregate in large numbers: the two biggest amusement parks in Dhaka,
By: A N M Al Imran, mHealth Specialist, TB CARE II Bangladesh Mr. Nizamul Islam serves as TB CARE II’s district coordinator in Chittagong district, Bangladesh. One of his responsibilities is distributing allowances to MDR TB patients and DOT providers in the district. Through TB CARE II, MDR TB patients receive allowances – small monetary payments – to help them buy extra food to support good nutrition during their treatment. DOT providers receive